abstract |
This present application refers to novel virus-like particles (VLPs), which are useful as immunomodulatory agents, compositions and uses thereof, as well as methods of treatment. The VLPs disclosed herein are target-driven and have immunomodulatory properties provided by heterologous molecules attached, or anchored, thereto. |